The role of optical coherence tomography in vascular medicine

Vascular Medicine - Tập 14 Số 1 - Trang 63-71 - 2009
Muhammad Farooq1, Atul Khasnis2, Arshad Majid1,3, Mounzer Kassab1,3
1Department of Neurology and Ophthalmology, Michigan State University, East Lansing, Michigan, USA
2Department of Rheumatology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
3Department of Neurology and Ophthalmology, Michigan State University, East Lansing, Michigan, USA; Department of Neurology and Ophthalmology, Division of Cerebrovascular Diseases and Interventional Neurology, Michigan State University, East Lansing, Michigan, USA

Tóm tắt

Abstract Optical coherence tomography (OCT) is an emerging imaging modality that provides high-resolution, microstructural information on atherosclerotic plaques in biological systems. Intracoronary OCT can identify thin-cap fibroatheroma and other vulnerable plaques that may be responsible for acute coronary events. These characteristics make OCT helpful in guiding coronary management and interventions, including stent apposition and early identification of procedure-related complications. OCT is being assessed for its potential role in carotid plaque characterization and in the diagnosis of peripheral arterial atherosclerosis. Its current use in studying carotid and cerebral vasculature and in the diagnosis of peripheral arterial diseases is limited and ill defined, but it is finding increasing application in these areas. Its performance can be further improved by increasing the signal to noise ratio and by using dynamic focus tracking techniques. It can potentially be used to monitor the progression and regression of atherosclerosis in the coronary, cerebral and peripheral vasculature. New indications for its use in vascular medicine are emerging as its technology continues to improve over time.

Từ khóa


Tài liệu tham khảo

10.1126/science.276.5321.2037

10.1161/01.CIR.93.6.1206

10.1038/sj.neo.7900071

10.1126/science.1957169

10.1364/OL.18.001864

10.1038/nbt892

10.1038/nm0995-970

10.1136/hrt.77.5.397

10.1111/j.1540-8183.2006.00201.x

10.1016/S0190-9622(97)70072-0

10.1055/s-2000-9626

10.1161/01.CIR.94.11.3013

10.1007/s00270-005-0176-z

10.1097/01.RVI.0000195324.52104.00

Satomura Y, 2004, Clin Hemorheol Microcirc, 31, 31

10.1161/01.CIR.93.7.1354

10.1161/01.CIR.0000087480.94275.97

10.1136/hrt.2004.041798

10.1161/01.CIR.104.3.365

10.1097/00001573-200109000-00006

10.1161/01.ATV.20.5.1262

10.1161/01.CIR.94.8.2013

10.1161/01.CIR.87.4.1179

10.1016/j.mcna.2007.03.004

10.1161/01.CIR.103.4.604

10.1080/14628840510011252

10.1097/00019501-200608000-00005

10.1111/j.1540-8183.2006.00099.x

10.1117/1.2192697

10.1161/01.CIR.0000029927.92825.F6

10.1093/eurheartj/ehi542

10.1136/hrt.2006.091918

10.1161/01.CIR.0000044384.41037.43

10.1016/j.ahj.2006.06.030

10.1016/j.ijcard.2005.11.036

10.1097/MCA.0b013e3282583be8

10.1016/j.jacc.2006.11.040

10.1016/S0735-1097(01)01799-5

10.1093/eurheartj/ehn132

10.1002/ccd.20340

10.1136/hrt.2005.065151

Suzuki Y, 2006, J Invasive Cardiol, 18, 111

Ito S, 2005, J Invasive Cardiol, 17, 369

10.1536/ihj.46.1133

10.1093/eurheartj/ehl413

10.1097/00029330-200803020-00005

10.1067/msy.1998.91488

10.1067/mva.2002.126545

10.1161/hc2601.091704

10.1034/j.1600-0404.2000.101003188.x

10.1161/01.STR.26.10.1747

10.1161/01.CIR.102.9.959

10.1161/hs1101.098663

10.1161/hc4201.097839

10.1161/01.STR.0000231648.74198.f7

10.1016/j.surneu.2006.09.037

10.1161/CIRCULATIONAHA.104.528174

10.1080/02688690701400775

10.1016/j.atherosclerosis.2007.02.004

10.1161/01.ATV.0000222920.59760.df

10.7863/jum.2001.20.5.451

10.1161/01.STR.0000013562.73522.82

10.1016/j.atherosclerosis.2006.08.047

10.1063/1.1879096

10.1117/1.2358960

10.3171/jns.2005.102.2.0348

10.1016/j.ultrasmedbio.2006.07.020

10.1016/j.jacc.2005.10.067

10.1161/01.CIR.103.15.1999

10.1117/1.2333613